Vanguard Group’s Bristol-Myers Squibb BMY Stock Holding History

Vanguard Group’s Portfolio BMY Stock Details BMY Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$9.02B	Buy	194,925,206 +3,522,202	+2%	+$163M	0.15%	117
2025 Q1	$11.7B	Buy	191,403,004 +1,458,488	+0.8%	+$89M	0.21%	82
2024 Q4	$10.7B	Buy	189,944,516 +1,373,209	+0.7%	+$77.7M	0.19%	87
2024 Q3	$9.76B	Buy	188,571,307 +2,000,150	+1%	+$103M	0.17%	99
2024 Q2	$7.75B	Buy	186,571,157 +504,048	+0.3%	+$20.9M	0.15%	116
2024 Q1	$10.1B	Sell	186,067,109 -12,092,663	-6%	-$656M	0.2%	85
2023 Q4	$10.2B	Sell	198,159,772 -1,583,477	-0.8%	-$81.2M	0.22%	77
2023 Q3	$11.6B	Sell	199,743,249 -4,001,033	-2%	-$232M	0.28%	54
2023 Q2	$13B	Sell	203,744,282 -852,219	-0.4%	-$54.5M	0.31%	50
2023 Q1	$14.2B	Buy	204,596,501 +1,668,881	+0.8%	+$116M	0.36%	42
2022 Q4	$14.6B	Buy	202,927,620 +3,041,035	+2%	+$219M	0.4%	36
2022 Q3	$14.2B	Buy	199,886,585 +3,058,491	+2%	+$217M	0.42%	35
2022 Q2	$15.2B	Sell	196,828,094 -1,661,990	-0.8%	-$128M	0.43%	37
2022 Q1	$14.5B	Sell	198,490,084 -1,344,399	-0.7%	-$98.2M	0.34%	50
2021 Q4	$12.5B	Buy	199,834,483 +903,084	+0.5%	+$56.3M	0.28%	57
2021 Q3	$11.8B	Buy	198,931,399 +1,589,969	+0.8%	+$94.1M	0.29%	57
2021 Q2	$13.2B	Buy	197,341,430 +676,121	+0.3%	+$45.2M	0.33%	51
2021 Q1	$12.4B	Sell	196,665,309 -2,675,149	-1%	-$169M	0.34%	50
2020 Q4	$12.4B	Sell	199,340,458 -725,134	-0.4%	-$45M	0.36%	49
2020 Q3	$12.1B	Sell	200,065,592 -3,822,794	-2%	-$230M	0.4%	48
2020 Q2	$12B	Buy	203,888,386 +4,984,471	+3%	+$293M	0.43%	40
2020 Q1	$11.1B	Buy	198,903,915 +4,043,761	+2%	+$225M	0.47%	38
2019 Q4	$12.5B	Buy	194,860,154 +60,430,418	+45%	+$3.88B	0.43%	38
2019 Q3	$6.82B	Buy	134,429,736 +371,100	+0.3%	+$18.8M	0.25%	67
2019 Q2	$6.08B	Buy	134,058,636 +1,580,750	+1%	+$71.7M	0.23%	75
2019 Q1	$6.32B	Buy	132,477,886 +778,291	+0.6%	+$37.1M	0.25%	70
2018 Q4	$6.85B	Buy	131,699,595 +3,323,436	+3%	+$173M	0.31%	60
2018 Q3	$7.97B	Buy	128,376,159 +1,229,553	+1%	+$76.3M	0.31%	56
2018 Q2	$7.04B	Buy	127,146,606 +1,917,892	+2%	+$106M	0.29%	58
2018 Q1	$7.92B	Buy	125,228,714 +1,726,823	+1%	+$109M	0.35%	48
2017 Q4	$7.57B	Buy	123,501,891 +1,712,922	+1%	+$105M	0.33%	50
2017 Q3	$7.76B	Buy	121,788,969 +3,127,279	+3%	+$199M	0.36%	44
2017 Q2	$6.61B	Buy	118,661,690 +333,685	+0.3%	+$18.6M	0.33%	47
2017 Q1	$6.43B	Buy	118,328,005 +3,516,801	+3%	+$191M	0.33%	45
2016 Q4	$6.71B	Buy	114,811,204 +2,098,453	+2%	+$123M	0.37%	42
2016 Q3	$6.08B	Buy	112,712,751 +3,157,920	+3%	+$170M	0.36%	46
2016 Q2	$8.06B	Buy	109,554,831 +3,595,648	+3%	+$264M	0.5%	34
2016 Q1	$6.77B	Buy	105,959,183 +4,982,057	+5%	+$318M	0.44%	41
2015 Q4	$6.95B	Buy	100,977,126 +2,396,947	+2%	+$165M	0.47%	35
2015 Q3	$5.84B	Buy	98,580,179 +1,362,337	+1%	+$80.7M	0.42%	39
2015 Q2	$6.47B	Buy	97,217,842 +2,599,931	+3%	+$173M	0.44%	40
2015 Q1	$6.1B	Buy	94,617,911 +3,295,051	+4%	+$213M	0.41%	42
2014 Q4	$5.39B	Buy	91,322,860 +5,064,692	+6%	+$299M	0.39%	42
2014 Q3	$4.41B	Buy	86,258,168 +2,101,259	+2%	+$108M	0.34%	48
2014 Q2	$4.08B	Buy	84,156,909 +1,975,066	+2%	+$95.8M	0.32%	48
2014 Q1	$4.27B	Buy	82,181,843 +2,160,320	+3%	+$112M	0.36%	46
2013 Q4	$4.25B	Buy	80,021,523 +1,317,054	+2%	+$70M	0.37%	45
2013 Q3	$3.64B	Buy	78,704,469 +1,855,562	+2%	+$85.9M	0.36%	42
2013 Q2	$3.43B	Buy	+76,848,907	New	+$3.43B	0.36%	43